MKM timeline
Every MKM batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| MKM-2606-K5012 | Adipotide | 10 Jun 2026 | 2026-Q3 | 6 | 97.71 | 1.13 | 97.92 | +0.21 | |
| MKM-2605-X3574 | BPC-157 | 14 May 2026 | 2026-Q2 | 3 | 98.63 | 0.52 | 98.50 | -0.13 | |
| MKM-2604-A3595 | Gonadorelin | 01 Apr 2026 | 2026-Q2 | 2 | 99.42 | 0.16 | 99.27 | -0.15 | |
| MKM-2603-V3346 | CJC-1295 (no DAC) | 24 Mar 2026 | 2026-Q3 | 9 | 99.44 | 1.28 | 99.31 | -0.13 | |
| MKM-2602-X4844 | L-Glutathione (reduced) | 27 Feb 2026 | 2026-Q2 | 5 | 98.50 | 0.30 | 98.00 | -0.50 | |
| MKM-2602-M2972 | CJC-1295 with DAC | 16 Feb 2026 | 2026-Q1 | 1 | 99.10 | n<2 | 99.59 | +0.49 | |
| MKM-2601-Y4342 | Semaglutide | 27 Jan 2026 | 2026-Q2 | 11 | 98.09 | 1.78 | 97.85 | -0.24 | |
| MKM-2512-B3991 | Semax | 25 Dec 2025 | 2026-Q2 | 11 | 98.75 | 1.46 | 99.00 | +0.25 | |
| MKM-2512-Y4110 | CJC-1295 (no DAC) | 22 Dec 2025 | 2026-Q2 | 6 | 98.86 | 0.93 | 99.23 | +0.37 | |
| MKM-2512-T3523 | Selank | 05 Dec 2025 | 2026-Q1 | 6 | 99.74 | 0.47 | 99.35 | -0.39 | |
| MKM-2511-N3837 | Mazdutide | 20 Nov 2025 | 2026-Q2 | 8 | 98.60 | 0.70 | 98.22 | -0.38 | |
| MKM-2511-F3656 | Adipotide | 20 Nov 2025 | 2026-Q1 | 9 | 98.84 | 0.90 | 98.30 | -0.54 | |
| MKM-2511-F3901 | L-Glutathione (reduced) | 15 Nov 2025 | 2026-Q2 | 3 | 98.79 | 0.18 | 99.01 | +0.22 | |
| MKM-2510-S3812 | Semaglutide | 11 Oct 2025 | 2026-Q1 | 4 | 98.63 | 0.34 | 98.81 | +0.18 | |
| MKM-2509-T3949 | MK-677 (Ibutamoren mesylate) | 20 Sep 2025 | 2026-Q1 | 6 | 99.33 | 0.62 | 98.80 | -0.53 | |
| MKM-2509-B4043 | PT-141 (Bremelanotide) | 01 Sep 2025 | 2025-Q4 | 14 | 99.39 | 0.93 | 99.33 | -0.06 | |
| MKM-2508-P4928 | Liraglutide | 29 Aug 2025 | 2025-Q3 | 10 | 98.06 | 1.63 | 98.27 | +0.21 | |
| MKM-2508-R3717 | Semaglutide | 26 Aug 2025 | 2026-Q1 | 11 | 98.90 | 1.38 | 98.49 | -0.41 | |
| MKM-2508-K4002 | 5-Amino-1MQ | 10 Aug 2025 | 2025-Q3 | 3 | 99.01 | 0.73 | 98.98 | -0.03 | |
| MKM-2507-D4229 | Semaglutide | 24 Jul 2025 | 2025-Q4 | 3 | 98.86 | 0.39 | 98.54 | -0.32 | |
| MKM-2506-D4138 | BPC-157 | 29 Jun 2025 | 2025-Q4 | 4 | 98.63 | 0.27 | 99.21 | +0.58 | |
| MKM-2506-K3642 | GHRP-2 | 23 Jun 2025 | 2025-Q4 | 1 | 99.48 | n<2 | 99.21 | -0.27 | |
| MKM-2506-T3988 | 5-Amino-1MQ | 02 Jun 2025 | 2025-Q4 | 2 | 99.10 | 0.32 | 99.17 | +0.07 | |
| MKM-2504-N4424 | Ipamorelin | 25 Apr 2025 | 2025-Q3 | 8 | 99.12 | 0.84 | 99.35 | +0.23 | |
| MKM-2504-N4868 | KPV | 21 Apr 2025 | 2025-Q2 | 12 | 99.90 | 0.50 | 99.10 | -0.80 | |
| MKM-2504-K3480 | CJC-1295 (no DAC) | 04 Apr 2025 | 2025-Q3 | 6 | 98.59 | 0.85 | 98.23 | -0.36 | |
| MKM-2503-H3929 | 5-Amino-1MQ | 06 Mar 2025 | 2025-Q3 | 10 | 99.58 | 0.85 | 99.83 | +0.25 | |
| MKM-2502-T3877 | BPC-157 | 03 Feb 2025 | 2025-Q3 | 5 | 98.88 | 1.27 | 98.66 | -0.22 | |
| MKM-2501-U4114 | IGF-1 LR3 | 11 Jan 2025 | 2025-Q2 | 2 | 97.92 | 0.04 | 97.85 | -0.07 | |
| MKM-2411-E4057 | Survodutide | 28 Nov 2024 | 2025-Q2 | 4 | 97.66 | 0.58 | 97.79 | +0.13 | |
| MKM-2411-B3993 | Tirzepatide | 19 Nov 2024 | 2025-Q2 | 10 | 98.07 | 1.18 | 98.78 | +0.71 | |
| MKM-2409-W4971 | CJC-1295 with DAC | 13 Sep 2024 | 2025-Q1 | 2 | 99.04 | 0.12 | 99.21 | +0.17 | |
| MKM-2408-L3879 | Enclomiphene citrate | 26 Aug 2024 | 2025-Q1 | 2 | 98.85 | 0.27 | 99.28 | +0.43 | |
| MKM-2407-Y4392 | Semax | 19 Jul 2024 | 2024-Q3 | 7 | 99.60 | 0.46 | 99.30 | -0.30 | |
| MKM-2406-H3711 | PT-141 (Bremelanotide) | 16 Jun 2024 | 2024-Q3 | 3 | 98.33 | 0.61 | 98.20 | -0.13 | |
| MKM-2405-A3531 | GHRP-2 | 31 May 2024 | 2024-Q4 | 1 | 98.80 | n<2 | 99.23 | +0.43 | |
| MKM-2404-E3617 | PT-141 (Bremelanotide) | 29 Apr 2024 | 2024-Q3 | 5 | 99.90 | 0.15 | 99.90 | 0.00 | |
| MKM-2403-C4617 | Semaglutide | 26 Mar 2024 | 2024-Q2 | 13 | 98.73 | 1.44 | 99.44 | +0.71 | |
| MKM-2402-N4278 | TB-500 | 02 Feb 2024 | 2024-Q2 | 1 | 99.78 | n<2 | 99.74 | -0.04 |